- 2026-03-18 16:11hCES2A-IN-1
- 2026-03-18 16:11hCES2-IN-1 2994634-52-3
- 2026-03-18 16:11hCAIX-IN-15 2849348-43-0
- 2026-03-18 16:11HbF inducer-1
- 2026-03-18 16:11HA-CD44 interaction inhibitor 1
- 2026-03-18 16:11Guraxetan
- 2026-03-18 16:11GTI 2040 sodium
- 2026-03-18 16:11GPR61 Inverse agonist 1
- 2026-03-18 16:11GPR34 receptor antagonist 3
- 2026-03-18 16:11GPR132 antagonist 1 898211-21-7
- 2026-03-18 16:11GNE-235
- 2026-03-18 16:11GMT 9 aptamer sodium
- 2026-03-18 16:10GMT 8 aptamer sodium
- 2026-03-18 16:10GMT 5 aptamer sodium
- 2026-03-18 16:10GMT 4 aptamer sodium
- 2026-03-18 16:10GMT 3 aptamer sodium
- 2026-03-18 16:10Glycerophosphoric acid disodium salt hydrate (α and β mixture)
- 2026-03-18 16:10GLUT1-IN-3
- 2026-03-18 16:10GK83
- 2026-03-18 16:10Geraniol-primeveroside
